Therapeutic Autologous Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant

This study has been terminated.

Study NCT00052598 Information provided by Fred Hutchinson Cancer Research Center

First Received: January 24, 2003 Last Updated: July 12, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	June 2011
Primary Completion Date:	November 2009 (Final data collection date for primary outcome measure)